Wholesale China Niacinamide Acid Quotes Manufacturer - UniAPI-PBS / Polymyxin B sulfate – Uniproma

Short Description:


Product Detail

Product Tags

Related Video

Feedback (2)

Like a result of ours specialty and repair consciousness, our enterprise has won a superb popularity amid buyers everywhere in the environment for Spf Spray For Face , A To Z Multivitamin , Enhance Skin Elasticity , Welcome your traveling to and any your inquires,sincerely hope we could have chance to cooperate along with you and we can build-up extensive nicely small business romantic relationship along with you.
Wholesale China Niacinamide Acid Quotes Manufacturer - UniAPI-PBS / Polymyxin B sulfate – Uniproma Detail:

Product Paramete

Trade name UniAPI-PBS
CAS 1405-20-5
Product Name Polymyxin B sulfate
Appearance White or almost white powder
Solubility Water soluble
Application Medicine
Assay The sum of polymyxin B1, B2, B3 and B1-I: 80.0% minPolymyxin B3: 6.0% maxPolymyxin B1-I: 15.0% max
Package 1kg net per aluminum can
Shelf life 2 years
Storage Store in cool and dry place, away from light. 2~8℃ for storage.
Chemical Structure

Application

Polyxin B sulfate is a cationic surfactant antibiotic, a mixture of polyxin B1 and B2, which can improve the permeability of cell membrane. Almost odourless. Sensitive to light. Hygroscopic. Soluble in water, slightly soluble in ethanol.

Clinical effect

Its antibacterial spectrum and clinical application are similar to polymyxin e. it has inhibitory or bactericidal effects on Gram-negative bacteria, such as Escherichia coli, Pseudomonas aeruginosa, paraescherichia coli, Klebsiella pneumoniae, acidophilus, pertussis and dysentery. Clinically, it is mainly used for infection caused by sensitive bacteria, urinary system infection caused by Pseudomonas aeruginosa, eye, trachea, meningitis, sepsis, burn infection, skin and mucous membrane infection, etc

pharmacological action

It has antibacterial effect on Pseudomonas aeruginosa, Escherichia coli, Klebsiella pneumoniae, Haemophilus, enterobacter, Salmonella, Shigella, pertussis, pasteurella and Vibrio. Proteus, Neisseria, Serratia, pruvidens, Gram-positive bacteria and obligate anaerobes were not sensitive to these drugs. There was cross resistance between this drug and polymyxin E, but there was no cross resistance between this drug and other antibiotics.

It is mainly used for wound, urinary tract, eye, ear, trachea infection caused by Pseudomonas aeruginosa and other Pseudomonas. It can also be used for sepsis and peritonitis.

 


Product detail pictures:

Wholesale China Niacinamide Acid Quotes Manufacturer - UniAPI-PBS / Polymyxin B sulfate  – Uniproma detail pictures


Related Product Guide:

Adhering to the principle of "quality, service, efficiency and growth", we have gained trusts and praises from domestic and international client for Wholesale China Niacinamide Acid Quotes Manufacturer - UniAPI-PBS / Polymyxin B sulfate – Uniproma, The product will supply to all over the world, such as: Montreal, Portugal, Saudi Arabia, When It produced, it making use of the world's major method for reliable operation, a low failure price, it appropriate for Jeddah shoppers choice. Our enterprise. s situated inside the national civilized cities, the website traffic is very hassle-free, unique geographical and financial circumstances. We pursue a "people-oriented, meticulous manufacturing, brainstorm, make brilliant" company philosophy. Strict good quality management, fantastic service, affordable cost in Jeddah is our stand around the premise of competitors. If needed, welcome to make contact with us by our web page or phone consultation, we'll be delighted to serve you.
  • We are a small company that has just started, but we get the company leader's attention and gave us a lot of help. Hope we can make progress together!
    5 Stars By Karen from Turkey - 2018.06.21 17:11
    This company can be well to meet our needs on product quantity and delivery time, so we always choose them when we have procurement requirements.
    5 Stars By Gemma from Czech Republic - 2018.07.12 12:19